Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

6,921 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Positive effects of methylphenidate on inattention and hyperactivity in pervasive developmental disorders: an analysis of secondary measures.
Posey DJ, Aman MG, McCracken JT, Scahill L, Tierney E, Arnold LE, Vitiello B, Chuang SZ, Davies M, Ramadan Y, Witwer AN, Swiezy NB, Cronin P, Shah B, Carroll DH, Young C, Wheeler C, McDougle CJ. Posey DJ, et al. Among authors: davies m. Biol Psychiatry. 2007 Feb 15;61(4):538-44. doi: 10.1016/j.biopsych.2006.09.028. Biol Psychiatry. 2007. PMID: 17276750 Clinical Trial.
Risperidone for the core symptom domains of autism: results from the study by the autism network of the research units on pediatric psychopharmacology.
McDougle CJ, Scahill L, Aman MG, McCracken JT, Tierney E, Davies M, Arnold LE, Posey DJ, Martin A, Ghuman JK, Shah B, Chuang SZ, Swiezy NB, Gonzalez NM, Hollway J, Koenig K, McGough JJ, Ritz L, Vitiello B. McDougle CJ, et al. Among authors: davies m. Am J Psychiatry. 2005 Jun;162(6):1142-8. doi: 10.1176/appi.ajp.162.6.1142. Am J Psychiatry. 2005. PMID: 15930063 Free article. Clinical Trial.
Positive effects of methylphenidate on hyperactivity are moderated by monoaminergic gene variants in children with autism spectrum disorders.
McCracken JT, Badashova KK, Posey DJ, Aman MG, Scahill L, Tierney E, Arnold LE, Vitiello B, Whelan F, Chuang SZ, Davies M, Shah B, McDougle CJ, Nurmi EL. McCracken JT, et al. Among authors: davies m. Pharmacogenomics J. 2014 Jun;14(3):295-302. doi: 10.1038/tpj.2013.23. Epub 2013 Jul 16. Pharmacogenomics J. 2014. PMID: 23856854 Free PMC article.
Parent-defined target symptoms respond to risperidone in RUPP autism study: customer approach to clinical trials.
Arnold LE, Vitiello B, McDougle C, Scahill L, Shah B, Gonzalez NM, Chuang S, Davies M, Hollway J, Aman MG, Cronin P, Koenig K, Kohn AE, McMahon DJ, Tierney E. Arnold LE, et al. Among authors: davies m. J Am Acad Child Adolesc Psychiatry. 2003 Dec;42(12):1443-50. doi: 10.1097/00004583-200312000-00011. J Am Acad Child Adolesc Psychiatry. 2003. PMID: 14627879 Clinical Trial.
Sequential pharmacotherapy for children with comorbid attention-deficit/hyperactivity and anxiety disorders.
Abikoff H, McGough J, Vitiello B, McCracken J, Davies M, Walkup J, Riddle M, Oatis M, Greenhill L, Skrobala A, March J, Gammon P, Robinson J, Lazell R, McMahon DJ, Ritz L; RUPP ADHD/Anxiety Study Group. Abikoff H, et al. Among authors: davies m. J Am Acad Child Adolesc Psychiatry. 2005 May;44(5):418-27. doi: 10.1097/01.chi.0000155320.52322.37. J Am Acad Child Adolesc Psychiatry. 2005. PMID: 15843763 Clinical Trial.
Efficacy and safety of immediate-release methylphenidate treatment for preschoolers with ADHD.
Greenhill L, Kollins S, Abikoff H, McCracken J, Riddle M, Swanson J, McGough J, Wigal S, Wigal T, Vitiello B, Skrobala A, Posner K, Ghuman J, Cunningham C, Davies M, Chuang S, Cooper T. Greenhill L, et al. Among authors: davies m. J Am Acad Child Adolesc Psychiatry. 2006 Nov;45(11):1284-1293. doi: 10.1097/01.chi.0000235077.32661.61. J Am Acad Child Adolesc Psychiatry. 2006. PMID: 17023867 Clinical Trial.
Pharmacogenetics of methylphenidate response in preschoolers with ADHD.
McGOUGH J, McCRACKEN J, Swanson J, Riddle M, Kollins S, Greenhill L, Abikoff H, Davies M, Chuang S, Wigal T, Wigal S, Posner K, Skrobala A, Kastelic E, Ghuman J, Cunningham C, Shigawa S, Moyzis R, Vitiello B. McGOUGH J, et al. Among authors: davies m. J Am Acad Child Adolesc Psychiatry. 2006 Nov;45(11):1314-1322. doi: 10.1097/01.chi.0000235083.40285.08. J Am Acad Child Adolesc Psychiatry. 2006. PMID: 17023870 Clinical Trial.
Safety and tolerability of methylphenidate in preschool children with ADHD.
Wigal T, Greenhill L, Chuang S, McGOUGH J, Vitiello B, Skrobala A, Swanson J, Wigal S, Abikoff H, Kollins S, McCRACKEN J, Riddle M, Posner K, Ghuman J, Davies M, Thorp B, Stehli A. Wigal T, et al. Among authors: davies m. J Am Acad Child Adolesc Psychiatry. 2006 Nov;45(11):1294-1303. doi: 10.1097/01.chi.0000235082.63156.27. J Am Acad Child Adolesc Psychiatry. 2006. PMID: 17028508 Clinical Trial.
Comorbidity moderates response to methylphenidate in the Preschoolers with Attention-Deficit/Hyperactivity Disorder Treatment Study (PATS).
Ghuman JK, Riddle MA, Vitiello B, Greenhill LL, Chuang SZ, Wigal SB, Kollins SH, Abikoff HB, McCracken JT, Kastelic E, Scharko AM, McGough JJ, Murray DW, Evans L, Swanson JM, Wigal T, Posner K, Cunningham C, Davies M, Skrobala AM. Ghuman JK, et al. Among authors: davies m. J Child Adolesc Psychopharmacol. 2007 Oct;17(5):563-80. doi: 10.1089/cap.2007.0071. J Child Adolesc Psychopharmacol. 2007. PMID: 17979578 Clinical Trial.
Methylphenidate effects on functional outcomes in the Preschoolers with Attention-Deficit/Hyperactivity Disorder Treatment Study (PATS).
Abikoff HB, Vitiello B, Riddle MA, Cunningham C, Greenhill LL, Swanson JM, Chuang SZ, Davies M, Kastelic E, Wigal SB, Evans L, Ghuman JK, Kollins SH, McCracken JT, McGough JJ, Murray DW, Posner K, Skrobala AM, Wigal T. Abikoff HB, et al. Among authors: davies m. J Child Adolesc Psychopharmacol. 2007 Oct;17(5):581-92. doi: 10.1089/cap.2007.0068. J Child Adolesc Psychopharmacol. 2007. PMID: 17979579 Clinical Trial.
6,921 results